Allspring Global Investments Holdings, LLC Viracta Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $59.4 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022
SELL
$1.87 - $5.0 $164,176 - $438,975
-87,795 Closed
0 $0
Q1 2022

May 02, 2022
BUY
$2.23 - $4.76 $32,968 - $70,371
14,784 Added 20.25%
87,795 $417,000
Q4 2021

Jan 28, 2022
BUY
$3.37 - $7.91 $246,047 - $577,517
73,011 New
73,011 $266,000

Others Institutions Holding VIRX

# of Institutions
44
Shares Held
9.03M
Call Options Held
10.9K
Put Options Held
400
View Full List

About Viracta Therapeutics, Inc.

VIRX Quotes by TradingView
  • Ticker VIRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,558,200
  • Market Cap $8.64M
  • Description
  • Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...
More about VIRX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email